Back to Search
Start Over
LakeShore`s YSJA rabies vaccine receives approval for Phase III trial in China
- Source :
- The Fly. October 25, 2024
- Publication Year :
- 2024
-
Abstract
- LakeShore Biopharma announced that it has been granted approval for a Phase III clinical trial by the National Medical Products Administration, or NMPA, in China to explore the immunogenicity and [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.813592706